Current potential biomarkers for Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis: review of literature
Abstract
INTRODUCTION: Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) are several common neurodegenerative diseases (NDs). At present, is the lack of effective diagnosis, progression, prognosis and therapeutic biomarkers. it is a urgent demand to search the relevant confident biomarkers. AREA COVERED: This review systematically analysed the potential biomarkers of blood, cerebrospinal fluid, neuroimaing and emerging non-invasive indicators, and synthesises current evidences on the biomarkers of AD, PD and ALS about diagnosis, progression, prognosis and therapeutic, especially diagnosis biomarkers. EXPERT COMMENTARY: In this review, we focus on discussing relevant diagnosis, progression, prognosis and therapeutic biomarkers for AD, PD and ALS in recent years, and prospecting the possible future directions of relevant biomarkers.
Fields of Study & Subjects
Amyotrophic Lateral Sclerosis Research
Phosphodiesterase function and regulation
Alzheimer's disease research and treatments
Publication details
- Journal / source
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Volume
- 28
- Issue
- 1
- Pages
- 62–84
- Publication date
- 6 February 2026
- Language
- EN